Unsupported browser

You are using an outdated browser. Please upgrade your browser to improve your experience.

Sign up for an Award

Participate with your entry in one of our professional or student awards.

Sign up for an award

Sign up for a Profile

Create your own profile and publish it in the iF WORLD DESIGN GUIDE.

Sign up for a profile

Learn more:

iF SOCIAL IMPACT PRIZE

Present your project for free and win your share of EUR 50,000 in prize money.

Publish your project

Hepatus Series / Non-invasive fibrosis evaluation system

Hepatus Series

Discipline: Product

Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series

Discipline: Product

This device series opens up a new era for non-invasive liver disease diagnosis. It is suitable for the quantitative diagnosis of liver fibrosis and fatty liver caused by various chronic liver diseases. It supports early detection, diagnosis, treatment, and rehabilitation of various chronic liver diseases. Recommend by global liver disease guidelines, non-invasive quantitative analysis of fibrosis is the first step in chronic liver disease assessment.

  • DATE OF LAUNCH 2020

  • DEVELOPMENT TIME 25 - 36 months

  • TARGET REGIONS Asia, Europe, North America, South America

  • TARGET GROUPS Consumer / User

Client / Manufacturer

Shenzhen Mindray Biomedical Electronics Co., Ltd.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen, China

Go to profile
Design

Shenzhen Mindray Biomedical Electronics Co., Ltd.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen, China

Jinzhou Zhao, Linghui Kuang, Bo Huang, Lang Lang

Go to profile